MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

University of Missouri (MU)

Status: Completed

Conditions: Vertigo; Coronary Artery Disease; Tobacco Use Cessation; Migraine Disorders; Hypothyroidism; Obesity; HIV Infections; Shoulder Pain; Irritable Bowel Syndrome; Sleep Initiation and Maintenance Disorders; Osteoarthritis; Hyperlipidemia; Diarrhea; Chronic Obstructive Pulmonary Disease; Gastroesophageal Reflux; Vaginitis; Bursitis; Sinusitis; Senile Osteoporosis; Fibromyalgia; Back Pain; Urinary Tract Infection; Menopause; Diabetes Mellitus; Cough; Allergic Rhinitis; Anxiety; Smoking Cessation; Headache; Hypertension; Asthma; Influenza; Acne Vulgaris; Depression; Prostatic Hyperplasia; Urinary Incontinence; Obstructive Sleep Apnea

Treatments: Other: health information prescription

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT01050465

HHSN276200800445P

Details and patient eligibility

About

The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.

Full description

The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.

Primary Hypothesis. Individuals in the paper prescription group will be just as likely to seek information using MedlinePlus compared with individuals in the group who receive the same customized information through an email prescription.

Secondary Hypothesis. Individuals in the paper prescription group will be just as likely to have successful behavioral outcome measures as those in the group who receive the same customized information through an email prescription.

Enrollment: 907 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• one of the 40 target health conditions.

Exclusion Criteria

• absence of at least one of the target 40 conditions

Trial design

907 participants in 2 patient groups

email

Active Comparator group

Description:

Patients randomized to this arm will receive an email health information prescription.

Treatment:

Other: health information prescription

paper

Active Comparator group

Description:

Patients randomized to this arm will receive a paper health information prescription.

Treatment:

Other: health information prescription